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Abstract: *URZLQJEXUGHQRILQIHFWLRXVDQG1&'VDFURVV$IULFDHJRIZRUOG¶V+,9SDWLHQWVOLYH
in sub-Sahara Africa and 30 to 45% of adults have hypertension. This requires groups to collaborate. 
This is happening, e.g. SAHTAS, PharfA and MURIA. MURIA is researching antibiotic use, adherence 
to medicines and strengthening DTCs. This should continue to optimise medicine use and scarce 
resources. 
 
Introduction: The socioeconomic burden of diseases is increasing in Africa. For instance in 2011, 70% 
of the ZRUOG¶V+,9SRSXODWLRQUHVLGHGLQVXE-Sahara Africa. There are also growing rates of AMR, 
which necessitates newer more expensive antibiotics adding to costs. There is also a growing burden 
of NCDs, 3 out of 4 patients with hypertension currently live in LMICs, with prevalence rates up to 
30% to 45% among adults in Africa. Alongside this, up to 70% of total healthcare expenditure is spent 
on medicines in LMICs; much of this out-of-pocket. Consequently, an urgent need to strengthen 
collaborative research to improve medicine use. 
 
Method: Summary of groups working together in Africa including the Medicines Utilisation Research in 
Africa (MURIA) group.  
 
Results: African Strategies for Health identifies and advocates best practices, as well as works with 
others to develop sustainable solutions. Pharmacology for Africa (PharfA) organises and promotes 
pharmacology on the African continent, including research in clinical pharmacology, alongside the 
IUPHAR sub-division. ISPOR Africa co-ordinates activities from the different African country chapters. 
SAHTAS is a scientific and professional society for all those who produce, use, or encounter HTA in 
Southern Africa, and WHO International and Regional groups are improving antibiotic drug utilisation 
capabilities in Africa. The MURIA group was established in 2015 [1]. Ongoing collaborative research 
includes (i) initiatives to optimise antibiotic use; (ii) methods to enhance adherence to anti-infective 
prescribing guidance, (iii) approaches to improve adherence to HIV and NCDs; (iv) researching 
current anti-hypertensive and anti-diabetes medicines utilisation patterns and knowledge; (v) 
approaches to enhance DTC activities, and (vi) strengthening medicine utilisation capabilities [2,3]. 
These activities have already strengthened research ties across Africa. 
 
Conclusion: A number of groups are already working across Africa to enhance appropriate medicine 
use, and should continue. Ongoing MURIA activities include antibiotic point-prevalence studies, 
ongoing research into infectious diseases, NCDs and DTCs including adherence as well as the third 
workshop and symposium in Namibia in 2017. 
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